Innovation in Actinic Keratosis Assessment: Artificial Intelligence-Based Approach to LC-OCT PRO Score Evaluation.

PRO score assessment actinic keratosis (AK) artificial intelligence line-field optical coherence tomography non-melanoma skin cancer

Journal

Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829

Informations de publication

Date de publication:
07 Sep 2023
Historique:
received: 02 08 2023
revised: 26 08 2023
accepted: 01 09 2023
medline: 28 9 2023
pubmed: 28 9 2023
entrez: 28 9 2023
Statut: epublish

Résumé

Actinic keratosis (AK) is a common skin cancer in situ that can progress to invasive SCC. Line-field confocal optical coherence tomography (LC-OCT) has emerged as a non-invasive imaging technique that can aid in diagnosis. Recently, machine-learning algorithms have been developed that can automatically assess the PRO score of AKs based on the dermo-epidermal junction's (DEJ's) protrusion on LC-OCT images. A dataset of 19.898 LC-OCT images from 80 histologically confirmed AK lesions was used to test the performance of a previous validated artificial intelligence (AI)-based LC-OCT assessment algorithm. AI-based PRO score assessment was compared to the imaging experts' visual score. Additionally, undulation of the DEJ, the number of protrusions detected within the image, and the maximum depth of the protrusions were computed. Our results show that AI-automated PRO grading is highly comparable to the visual score, with an agreement of 71.3% for the lesions evaluated. Furthermore, this AI-based assessment was significantly faster than the regular visual PRO score assessment. The results confirm our previous findings of the pilot study in a larger cohort that the AI-based grading of LC-OCT images is a reliable and fast tool to optimize the efficiency of visual PRO score grading. This technology has the potential to improve the accuracy and speed of AK diagnosis and may lead to better clinical outcomes for patients.

Identifiants

pubmed: 37760425
pii: cancers15184457
doi: 10.3390/cancers15184457
pmc: PMC10527366
pii:
doi:

Types de publication

Journal Article

Langues

eng

Références

Ital J Dermatol Venerol. 2023 Jun;158(3):180-189
pubmed: 37278496
Am J Clin Dermatol. 2020 Feb;21(1):41-47
pubmed: 31278649
J Eur Acad Dermatol Venereol. 2016 Aug;30(8):1303-7
pubmed: 26955898
J Dtsch Dermatol Ges. 2020 Mar;18(3):275-294
pubmed: 32130773
Br J Dermatol. 2006 Nov;155(5):951-6
pubmed: 17034524
J Am Acad Dermatol. 2000 Jan;42(1 Pt 2):11-7
pubmed: 10607351
J Am Acad Dermatol. 2023 Jun;88(6):1317-1325
pubmed: 36841336
J Eur Acad Dermatol Venereol. 2015 May;29(5):991-7
pubmed: 25428612
Lancet. 1988 Apr 9;1(8589):795-7
pubmed: 2895318
Int J Gynecol Cancer. 2023 Apr 3;33(4):446-461
pubmed: 36958755
Br J Dermatol. 2019 Sep;181(3):544-553
pubmed: 30636037
Clin Exp Dermatol. 2021 Dec;46(8):1471-1481
pubmed: 34047380
Clin Dermatol. 2021 Jul-Aug;39(4):657-666
pubmed: 34809770
JAMA Dermatol. 2022 Jun 1;158(6):634-640
pubmed: 35475852
Nat Cancer. 2022 Sep;3(9):1026-1038
pubmed: 36138135
Cancer Commun (Lond). 2020 Apr;40(4):154-166
pubmed: 32277744
J Biophotonics. 2019 Jul;12(7):e201800391
pubmed: 30653833
Dermatol Pract Concept. 2020 Oct 26;10(4):e2020121
pubmed: 33150042
Nature. 2017 Feb 2;542(7639):115-118
pubmed: 28117445
Cancers (Basel). 2021 Jun 08;13(12):
pubmed: 34201052
J Dtsch Dermatol Ges. 2018 Aug;16(8):1002-1013
pubmed: 30117703
Ann Gastroenterol. 2019 May-Jun;32(3):257-263
pubmed: 31040622
Br J Dermatol. 2007 May;156 Suppl 3:8-12
pubmed: 17488400
FASEB J. 2020 Sep;34(9):13022-13032
pubmed: 32776588
J Eur Acad Dermatol Venereol. 2018 May;32(5):745-751
pubmed: 28796914
J Eur Acad Dermatol Venereol. 2019 Jun;33(6):1092-1097
pubmed: 30887613
Int J Environ Res Public Health. 2021 Dec 20;18(24):
pubmed: 34949015
J Dtsch Dermatol Ges. 2023 Sep 14;:
pubmed: 37707430
Br J Dermatol. 2019 Apr;180(4):916-921
pubmed: 29526028
Insights Imaging. 2018 Aug;9(4):611-629
pubmed: 29934920
J Med Imaging Radiat Sci. 2019 Dec;50(4):477-487
pubmed: 31601480
Australas J Dermatol. 2023 Feb;64(1):80-91
pubmed: 36645414

Auteurs

Fabia Daxenberger (F)

Department of Dermatology and Allergy, University Hospital, Ludwig Maximilian University of Munich, 80337 Munich, Germany.

Maximilian Deußing (M)

Department of Dermatology and Allergy, University Hospital, Ludwig Maximilian University of Munich, 80337 Munich, Germany.

Quirine Eijkenboom (Q)

Department of Dermatology and Allergy, University Hospital, Ludwig Maximilian University of Munich, 80337 Munich, Germany.

Charlotte Gust (C)

Department of Dermatology and Allergy, University Hospital, Ludwig Maximilian University of Munich, 80337 Munich, Germany.

Janis Thamm (J)

Department of Dermatology and Allergology, University Hospital, University of Augsburg, 86179 Augsburg, Germany.

Daniela Hartmann (D)

Department of Dermatology and Allergy, University Hospital, Ludwig Maximilian University of Munich, 80337 Munich, Germany.

Lars E French (LE)

Department of Dermatology and Allergy, University Hospital, Ludwig Maximilian University of Munich, 80337 Munich, Germany.
Department of Dermatology & Cutaneous Surgery, Miller School of Medicine, University of Miami, Miami, FL 33136, USA.

Julia Welzel (J)

Department of Dermatology and Allergology, University Hospital, University of Augsburg, 86179 Augsburg, Germany.

Sandra Schuh (S)

Department of Dermatology and Allergology, University Hospital, University of Augsburg, 86179 Augsburg, Germany.

Elke C Sattler (EC)

Department of Dermatology and Allergy, University Hospital, Ludwig Maximilian University of Munich, 80337 Munich, Germany.

Classifications MeSH